Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
A. Di Federico
, L. Hong
, A. Elkrief
, R. Thummalapalli
, A. J. Cooper
, B. Ricciuti
, S. Digumarthy
, J. V. Alessi
, P. Gogia
, F. Pecci
, M. Makarem
, M. M. Gandhi
, E. Garbo
, A. Saini
, A. De Giglio
, V. Favorito
, S. Scalera
, L. Cipriani
, D. Marinelli
, D. Haradon
T. Nguyen, J. Haradon, E. Voligny, V. Vaz, F. Gelsomino, F. Sperandi, B. Melotti, M. Ladanyi, J. Zhang, D. L. Gibbons, J. V. Heymach, M. Nishino, J. Lindsay, S. J. Rodig, K. Pfaff, L. M. Sholl, X. Wang, B. E. Johnson, P. A. Jänne, N. Rekhtman, M. Maugeri-Saccà, R. S. Heist, A. Ardizzoni, M. M. Awad, K. C. Arbour, A. J. Schoenfeld, N. I. Vokes, J. Luo
Research output: Contribution to journal › Article › peer-review
25Scopus
citations
Fingerprint
Dive into the research topics of 'Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors'. Together they form a unique fingerprint.